Osteoarthritis
Conditions
Interventions
Patients will be randomised, stratified according to joint or non-joint disorder, to receive either:
1. General advice on NSAIDs (group 1)
2. Reduced NSAIDs plus advice on alternative treatments for t
Sponsors
NHS R&D Regional Programme Register - Department of Health (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Two general practices with computer generated register data will be invited to participate. Up to 260 patients receiving regular prescriptions for NSAIDs for regional locomotor pain will be identified according to the following criteria. 1. Adult (18 years or older, no upper age limit) 2. Oral NSAID prescriptions to cover at least 6 of the previous 12 months 3. Last prescription within 6 weeks of induction into study 4. Osteoarthritis or regional locomotor pain (e.g. shoulder lesion, neck pain, back pain) as the reason for prescription
Exclusion criteria
Exclusion criteria: Defined inflammatory arthritis (e.g. rheumatoid arthritis, ankylosin spondylitis, gout), bone malignancy or non-locomotor pain as reason for prescription (obtained from GP records)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed